Clinical Trial Update: Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients

View source ↗

Summary

Completion of a real-world intensive monitoring study evaluating the use of olaparib in Chinese patients with ovarian or prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer, Prostate Cancer | Status: COMPLETED